The US Centers for Disease Control and Prevention is currently investigating five hospitalizations that occurred in people ...

The European Commission (EC) has authorised the marketing of Bavarian Nordic's Vimkunya - the first chikungunya vaccine ...

Bhopal: Health authorities in Bhopal have intensified their monitoring and preventive efforts following a roughly 10% rise in ...

Five people have been hospitalized with cardiac and neurological symptoms after getting the chikungunya vaccine.

This partnership comprises a technology transfer of the current drug product manufacturing process for the Chikungunya ...

Biological E partners with Bavarian Nordic to expand access to Chikungunya Vaccine in low- and middle-income countries.

Two years on, Bavarian Nordic’s $380 million vaccine M&A move appears to be paying off. | Valneva may have won the ...

Hyderabad: Biological E. Limited has announced a strategic partnership with Bavarian Nordic A/S to expand access to Bavarian ...

Hyderabad: Biopharma player Biological E (BE) entered into a strategic partnership with Danish vaccine maker Bavarian Nordic ...

First chikungunya vaccine approved in Europe for persons as young as 12 years old. On track for launch in key European ...

If granted, IXCHIQ® will become the first vaccine against the chikungunya virus (CHIKV) available in the EU for adolescents 12 years of age and ...